Business Description
Synmosa Biopharma Corp
ISIN : TW0004114004
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | 2.34 | |||||
Interest Coverage | 11.5 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.41 | |||||
Beneish M-Score | -2.31 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.7 | |||||
3-Year EBITDA Growth Rate | 0.9 | |||||
3-Year EPS without NRI Growth Rate | 3.3 | |||||
3-Year FCF Growth Rate | 39.6 | |||||
3-Year Book Growth Rate | 12.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.15 | |||||
9-Day RSI | 26.82 | |||||
14-Day RSI | 36.44 | |||||
6-1 Month Momentum % | 6.67 | |||||
12-1 Month Momentum % | 13.58 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.22 | |||||
Quick Ratio | 1.46 | |||||
Cash Ratio | 0.85 | |||||
Days Inventory | 192.91 | |||||
Days Sales Outstanding | 73.29 | |||||
Days Payable | 49.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.62 | |||||
Dividend Payout Ratio | 0.31 | |||||
3-Year Dividend Growth Rate | 60.2 | |||||
Forward Dividend Yield % | 1.62 | |||||
5-Year Yield-on-Cost % | 8.71 | |||||
3-Year Average Share Buyback Ratio | -1.9 | |||||
Shareholder Yield % | 7.72 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.48 | |||||
Operating Margin % | 12.9 | |||||
Net Margin % | 13.29 | |||||
FCF Margin % | 4.54 | |||||
ROE % | 10.36 | |||||
ROA % | 5.77 | |||||
ROIC % | 5.41 | |||||
ROC (Joel Greenblatt) % | 10.29 | |||||
ROCE % | 7.61 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.56 | |||||
Forward PE Ratio | 16.52 | |||||
PE Ratio without NRI | 22.45 | |||||
Shiller PE Ratio | 35.55 | |||||
Price-to-Owner-Earnings | 30.85 | |||||
PEG Ratio | 0.99 | |||||
PS Ratio | 3.01 | |||||
PB Ratio | 2.27 | |||||
Price-to-Tangible-Book | 2.44 | |||||
Price-to-Free-Cash-Flow | 66.04 | |||||
Price-to-Operating-Cash-Flow | 29.31 | |||||
EV-to-EBIT | 22.37 | |||||
EV-to-EBITDA | 15.22 | |||||
EV-to-Revenue | 3.15 | |||||
EV-to-FCF | 70.11 | |||||
Price-to-Projected-FCF | 2.13 | |||||
Price-to-Median-PS-Value | 1.22 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.9 | |||||
Price-to-Graham-Number | 1.56 | |||||
Earnings Yield (Greenblatt) % | 4.48 | |||||
FCF Yield % | 1.51 | |||||
Forward Rate of Return (Yacktman) % | 21.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Synmosa Biopharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 5,185.853 | ||
EPS (TTM) (NT$) | 1.634 | ||
Beta | -0.32 | ||
Volatility % | 11.97 | ||
14-Day RSI | 36.44 | ||
14-Day ATR (NT$) | 0.333534 | ||
20-Day SMA (NT$) | 37.41 | ||
12-1 Month Momentum % | 13.58 | ||
52-Week Range (NT$) | 32.225853 - 39.669571 | ||
Shares Outstanding (Mil) | 423.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Synmosa Biopharma Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Synmosa Biopharma Corp Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Synmosa Biopharma Corp Frequently Asked Questions
What is Synmosa Biopharma Corp(ROCO:4114)'s stock price today?
When is next earnings date of Synmosa Biopharma Corp(ROCO:4114)?
Does Synmosa Biopharma Corp(ROCO:4114) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |